763178 |
FRONTIERS IN ONCOLOGY |
Anti-Tumor Activity of AZD4547 Against NTRK1 Fusion Positive Cancer Cells Through Inhibition of NTRKs |
2021-11-01 |
10.3389/fonc.2021.757598 |
Cho Hanna, Kim Namkyoung, Murakami Takashi, Sim Taebo |
763177 |
FRONTIERS IN ONCOLOGY |
Results of the ECHO (Eating habits CHanges in Oncologic patients) Survey: An Italian Cross-Sectional Multicentric Study to Explore Dietary Changes and Dietary Supplement Use, in Breast Cancer Survivors |
2021-11-01 |
10.3389/fonc.2021.705927 |
Caprara Greta, Tieri Maria, Fabi Alessandra, Guarneri Valentina, Falci Cristina, Dieci Maria Vittoria, Turazza Monica, Ballardini Bettina, Bin Alessandra, Cinieri Saverio, Vici Patrizia, Montagna Emilia, Zamagni Claudio, Mazzi Cristina, Modena Alessandra, Marchetti Fabiana, Verzè Matteo, Ghelfi Francesca, Titta Lucilla, Nicolis Fabrizio, Gori Stefania |
763176 |
FRONTIERS IN ONCOLOGY |
Studies of Glyoxalase 1-Linked Multidrug Resistance Reveal Glycolysis-Derived Reactive Metabolite, Methylglyoxal, Is a Common Contributor in Cancer Chemotherapy Targeting the Spliceosome |
2021-11-01 |
10.3389/fonc.2021.748698 |
Alhujaily Muhanad, Abbas Hafsa, Xue Mingzhan, de la Fuente Alberto, Rabbani Naila, Thornalley Paul J. |
763175 |
FRONTIERS IN ONCOLOGY |
Low Expression of SLC7A11 Confers Drug Resistance and Worse Survival in Ovarian Cancer via Inhibition of Cell Autophagy as a Competing Endogenous RNA |
2021-11-01 |
10.3389/fonc.2021.744940 |
Ke Yao, Chen Xiaoying, Su Yuting, Chen Cuilan, Lei Shunmei, Xia Lianping, Wei Dan, Zhang Han, Dong Caihua, Liu Xia, Yin Fuqiang |
763174 |
FRONTIERS IN ONCOLOGY |
Augmented Reality and Intraoperative Navigation in Sinonasal Malignancies: A Preclinical Study |
2021-11-01 |
10.3389/fonc.2021.723509 |
Sahovaler Axel, Chan Harley H. L., Gualtieri Tommaso, Daly Michael, Ferrari Marco, Vannelli Claire, Eu Donovan, Manojlovic-Kolarski Mirko, Orzell Susannah, Taboni Stefano, de Almeida John R., Goldstein David P., Deganello Alberto, Nicolai Piero, Gilbert Ralph W., Irish Jonathan C. |
763173 |
FRONTIERS IN ONCOLOGY |
The Ferroptosis-Related Noncoding RNA Signature as a Novel Prognostic Biomarker in the Tumor Microenvironment, Immunotherapy, and Drug Screening of Gastric Adenocarcinoma |
2021-11-01 |
10.3389/fonc.2021.778557 |
Chen Xinming, Zhu Zheng, Li Xiaoling, Yao Xinyue, Luo Lianxiang |
763172 |
FRONTIERS IN ONCOLOGY |
BI-RADS Reading of Non-Mass Lesions on DCE-MRI and Differential Diagnosis Performed by Radiomics and Deep Learning |
2021-11-01 |
10.3389/fonc.2021.728224 |
Zhou Jiejie, Liu Yan-Lin, Zhang Yang, Chen Jeon-Hor, Combs Freddie J., Parajuli Ritesh, Mehta Rita S., Liu Huiru, Chen Zhongwei, Zhao Youfan, Pan Zhifang, Wang Meihao, Yu Risheng, Su Min-Ying |
763171 |
FRONTIERS IN ONCOLOGY |
Development and Validation of the Individualized Prognostic Nomograms in Patients With Right- and Left-Sided Colon Cancer |
2021-11-01 |
10.3389/fonc.2021.709835 |
Luo Zai, Fu Zhongmao, Li Tengfei, Zhang Yuan, Zhang Jianming, Yang Yan, Yang Zhengfeng, Li Qi, Qiu Zhengjun, Huang Chen |
763170 |
FRONTIERS IN ONCOLOGY |
Loop-Mediated Isothermal Amplification Assay for Detecting Tumor Markers and Human Papillomavirus: Accuracy and Supplemental Diagnostic Value to Endovaginal MRI in Cervical Cancer |
2021-11-01 |
10.3389/fonc.2021.747614 |
Wormald Benjamin, Rodriguez-Manzano Jesus, Moser Nicolas, Pennisi Ivana, Ind Thomas E. J., Vroobel Katherine, Attygalle Ayoma, Georgiou Pantelis, deSouza Nandita M. |
763169 |
FRONTIERS IN ONCOLOGY |
Evaluation Expression of miR-146a and miR-155 in Non-Small-Cell Lung Cancer Patients |
2021-11-01 |
10.3389/fonc.2021.715677 |
Dezfuli Neda K., Alipoor Shamila D., Dalil Roofchayee Neda, Seyfi Sharareh, Salimi Babak, Adcock Ian M., Mortaz Esmaeil |